Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
5 raisons identifiées
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (5 thèses dirigées)
Référence presse grand public
Cité 5 fois dans les médias — pédagogie reconnue
Disponibilité géographique
3 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Autoanticorps et complément dans les myopathies nécrosantes auto-immunes : physiopathologie et développement préclinique de nouvelles thérapeutiques.
2024Doctorant·e : Sarah Julien
Dermatomyosites paranéoplasiques : rôle des anticorps anti-TIF1gamma et du cancer dans le déclenchement de la dermatomyosite
2019Doctorant·e : Audrey Aussy
Rôle des auto-anticorps et des molécules du CMH de classe I dans la physiopathologie des myopathies inflammatoires
2014Doctorant·e : Laurent Drouot
Développement et fonction des lymphocytes T régulateurs : rôle du corécepteur CD4, du G-CSF et des anti-TNF
2009Doctorant·e : Céline Blache
Lymphocytes T exprimant un récepteur chimérique pour l'antigène (CAR T cells) : caractérisation du produit d'aphérèse, modification des sous-populations lymphocytaires et transfection différentielle des lymphocytes T CD4+ et T CD8+ pour une meilleure efficacité et persistence.
Doctorant·e : Alexis Cuffel
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
53
53 articles ont été cités au moins 53fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
9 740
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
326
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
148
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Inserm · Normandie Université · Université de Rouen Normandie
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Development of an Ex Vivo Model of Focal Corneal Desiccation to Investigate the Pathophysiology of Corneal Dellen and Ulcers
2026ArticleCornea
Nanoparticles targeting liver sinusoidal endothelial cells improve tolerance to vector and transgene antigens through tolerance spreading
2026ArticleMolecular Therapy
Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate
2026ArticleClinical Immunology
Preclinical evidence of anti-CD19 CAR-T cell in vitro and in vivo efficacy against CD19-expressing acute myeloid leukemia
2026ArticleCurrent Research in Translational Medicine
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link
2025ArticleBone Marrow Transplantation
[Pathophysiology of myositis: inflammation, oxidative stress and mitochondrial dysfunction]
2025ArticleMédecine/Sciences
Routine Monitoring of CAR‐T‐Cells Expansion and Persistence in Patients With Aggressive Large B‐Cell Lymphoma by Flow Cytometry: A Single‐Center Experience
2025ArticleHematological Oncology
In immune-mediated necrotising myopathy, anti-HMGCR antibodies inhibit HMGCR activity, leading to the sarcoplasmic accumulation of lipid droplets and myofibres necrosis
2025ArticleAnnals of the Rheumatic Diseases
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET DU DR OLIVIER BOYER
URGENCES MEDICALES DE PARIS 24 RUE DE L EST, 75020 PARIS
CABINET DU DR OLIVIER BOYER
MONCEAU CLINIQUE INTERNATIONALE DU PARC 21 RUE DE CHAZELLES, 75017 PARIS
CABINET DU DR Olivier BOYER
URGENCES MEDICALES DE PARIS 178 BIS RUE DE VAUGIRARD, 75015 PARIS
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 La République du Centre · 24/10/2025
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxQdDU1Vm5ZajI5cVdOcXBhdmxzUW1mUnRiMVd0YkxON05YSWhNZmMyRE5OYVY5V3h0OVRZdS1oZnRHS1N6TE96OFhBdUNWQVdQaTlJSDhNTWs2d1QyaklHYnpTTnprVHBveDZqYnNkZEtSeTNobVAtV19lLVBUMVdEWFFHaGdoamF3cGdPTFZZRkdhNWVWNGlScFFHZ2U4aGtsc2cyU0xNTm1tZlJxVWM0S2FsVnktWXFmTm
📰 France 3 Régions · 04/09/2025
<a href="https://news.google.com/rss/articles/CBMiuAJBVV95cUxNRkxWUXZWa3VXazc4Tloyb0ZLSmVlMjhjSU1HcjdXbi1nM0piQ3pLX3NtekRfa2lPYi16MTB1QmE0aUlyaWhYR1JHdGJSNVpfTXBYSm5PSEZ0MGFaYnN6STJhblZXY3AwMGp6bVBLREFCWm9QR1prSlZEZVdmT2hSRmxEM1NyRmVUR1dNZDM5NDJQLVNIZFpKOWhIZHNjNGp6OGYxT3pqd2ZhOXZybGdHRl9VQ2lUWnF0T1
📰 La République du Centre · 04/09/2025
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNb0hOVUktQ2dkdUo4UDdyQnFKcXM2T3RKOUFUR2lDMV84SEwyTVNWeUh5SVJIS2xvZ0pCZ2dFME01MWJKN2pQU2ZaVTdXWW10VU04SmM5MTNIUFFKcE5xM1RXM0M0MDFiVlV5VW1DWHk4RElUMFFFa2pKeEE0Z29qRkFNOXdZcl90ZGF4Ykt2OWtWSjVBWTYzOGlMXzJxOFBKQmJ3aGFMcVlEUThwbzFtZFpvcWtzV3B0WF
📰 La République du Centre · 06/07/2025
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNOW9OdC1TeTZ6MjB2UWVpbkhGdmJvSG1wYzZMSVlOcnJFQ3FlcjRONTAwdHVyazJIMkVCay1qYjVQWFFyY2poWnRRRFpDU2hWTUhrLTl2Rk1lUnVvRkZ5LVU3VDJCYnVZanBGTklOZi1vRWJ2UWREM3J2TjhLMWQ0ZktOWlU0ZmV1SDBtOFlRQm11aHFMMTFSbDRSZGNpbGotUVdXT2tNR1MzUUdlbmZ5WXdUdHlWNzBhUF
📰 La République du Centre · 05/04/2016
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYkpRZGtyOTlnc1ctMmo5eFBXdXpVNk83dzQ2V3UzeGdPUHVOMXdmd3FISlNBLTVaRW5zVmJ1S2dOdUpoOC05bG9xQlcyNUo0eGtCaUpDbVltTnM0d0pJM2ZoLVNRdjdYMVR6RDBHeFNoTnVobmRKRnM1UXNZWVBOcjZvYlpoaDVWOVo2TjV0RngxU2xjMFBVMVdXQnFiMGM5OVg5UTNqbERWZw?oc=5" target="_blan
Pediatric nephrology (Berlin, Germany) · 2025
Abstract IgA nephropathy and IgA vasculitis with nephritis, albeit rare, represent two relatively frequent glomerular conditions in childhood. Compared to adults, pediatric IgA nephropathy has a more acute presentation, most frequently with synpharyngitic macrohematuria and histologically with more intense inflammation and less intense chronic damage. Management of these conditions is controversial and supported by little high-quality evidence. The paucity of evidence is due to the disease heterogeneity, its inter-ethnic variability, and the difficulty of extrapolating data from adult studies due to the peculiarities of the condition in children. IgA vasculitis with nephritis is a kidney manifestation of a systemic disorder, typical of the pediatric age, in which both the diagnosis of kidney involvement and its management are poorly defined, and an interdisciplinary approach is crucial. Both conditions can have a profound and long-lasting impact on kidney function and the global health of affected children. The International Pediatric Nephrology Association has therefore convened a diverse international group of experts from different disciplines to provide guidance on the recommended management of these conditions in children and to establish common definitions and define priorities for future high-quality, evidence-based collaborative studies for the benefit of children.
Nature communications · 2024
AbstractIdiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis.
Cell death & disease · 2023
AbstractAutologous T cells engineered to express a chimeric antigen receptor (CAR) specific for CD19 are approved for the treatment of various CD19+ hematological malignancies. While CAR T cells induce objective responses in a majority of patients, relapse frequently occurs upon loss of CD19 expression by neoplastic cells. Radiation therapy (RT) has been successfully employed to circumvent the loss of CAR targets in preclinical models of pancreatic cancer. At least in part, this reflects the ability of RT to elicit death receptor (DR) expression by malignant cells, enabling at least some degree of CAR-independent tumor killing. In a human model of CD19+ acute lymphoblastic leukemia (ALL), we also observed DR upregulation by RT, both in vitro and in vivo. Moreover, low-dose total body irradiation (LD-TBI) delivered to ALL-bearing mice prior to CAR T cell infusion considerably extended the overall survival benefit afforded by CAR T cells alone. Such an improved therapeutic activity was accompanied by a superior expansion of CAR T cells in vivo. These data encourage the initiation of clinical trials combining LD-TBI with CAR T cells in patients with hematological malignancies.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Molecular therapy : the journal of the American Society of Gene Therapy · 2026 · Journal Article
Hardet R, Wang SH, Delignat S, Blandin M, et al.
Bone marrow transplantation · 2026 · Journal Article
Chartral U, Galaine J, Giverne C, Auxenfans C, et al.
Current research in translational medicine · 2026 · Journal Article
Eugene Norbert M, Cuffel A, Martinet J, Jean L, et al.
The British journal of dermatology · 2026 · Journal Article
Tedbirt B, Calbo S, Lebourgeois L, Maho-Vaillant M, et al.
Cornea · 2026 · Journal Article
Gaulier A, Jaworski T, Vautier A, Lefevre S, et al.
Stem cells translational medicine · 2025 · Journal Article
Pileyre B, Gandolfi S, Abad C, Jaworski T, et al.
Bone marrow transplantation · 2025 · Published Erratum
Marton C, Clémenceau B, Dachy G, Demerle C, et al.
Annales pharmaceutiques francaises · 2025 · Journal Article
Cousin T, Chantreuil F, Barat E, Boyer O, et al.
Bone marrow transplantation · 2025 · Conference Proceedings
Boyer O, Bensoussan D, Bönig H, Chabannon C, et al.
bioRxiv : the preprint server for biology · 2025 · Journal Article
Alhomoud M, Foley M, Sugita M, Fein JA, et al.
Clinical and experimental rheumatology · 2025 · Editorial
Giannini M, Bhai S, Boyer O, Cheng K, et al.
Bone marrow transplantation · 2025 · Journal Article
Marton C, Clémenceau B, Dachy G, Demerle C, et al.
International journal of molecular sciences · 2025 · Journal Article
Abdoul-Azize S, Zoubairi R, Boyer O
Muscle & nerve · 2025 · Journal Article
Julien S, Tomasevic H, Jaworski T, Zoubairi R, et al.
Hematological oncology · 2025 · Journal Article
Zduniak A, Martinet J, Lévêque E, Becker S, et al.
Medecine sciences : M/S · 2025 · Journal Article
Abad C, Boyer O
Rheumatology (Oxford, England) · 2025 · Journal Article
Bader-Meunier B, Moreau TRJ, Aeschlimann F, Authier FJ, et al.
Annals of the rheumatic diseases · 2025 · Letter
Giannini M, Quiring G, Oulad-Abdelghani M, Lannes B, et al.
Joint bone spine · 2025 · Editorial
Brevet P, Fréret M, Barat E, Lequerré T, et al.
RMD open · 2024 · Letter
Brevet P, Boyer O, Vittecoq O, Fréret M
Rheumatology (Oxford, England) · 2024 · Letter
Nguyen HD, Jouen F, Déchelotte B, Cordel N, et al.
Nature communications · 2024 · Journal Article
Abad C, Pinal-Fernandez I, Guillou C, Bourdenet G, et al.
Nature communications · 2024 · Journal Article
Abdoul-Azize S, Hami R, Riou G, Derambure C, et al.
Antibodies (Basel, Switzerland) · 2024 · Journal Article
Julien S, Challier I, Malleter M, Jouen F, et al.
Journal of immunological methods · 2024 · Journal Article
Eugene-Norbert M, Cuffel A, Riou G, Jean L, et al.
Rheumatology (Oxford, England) · 2023 · Journal Article
Julien S, van der Woning B, De Ceuninck L, Briand E, et al.
Journal of refractive surgery (Thorofare, N.J. : 1995) · 2023 · Journal Article
Vautier A, Bourges JL, Gabison E, Chaventre F, et al.
Cell death & disease · 2023 · Journal Article
Sugita M, Yamazaki T, Alhomoud M, Martinet J, et al.
Rheumatology (Oxford, England) · 2023 · Journal Article
Cordel N, Dechelotte B, Jouen F, Lamb JA, et al.
Neuropathology and applied neurobiology · 2023 · Journal Article
Bourdenet G, Pileyre B, Drouot L, Martinet J, et al.
Allergy · 2022 · Letter
Lukaszewicz R, Mahay G, Boyer O, Martinet J
Biomedicines · 2022 · Journal Article
Julien S, Vadysirisack D, Sayegh C, Ragunathan S, et al.
JAMA dermatology · 2022 · Journal Article
Lemieux A, Maho-Vaillant M, Golinski ML, Hébert V, et al.
Kidney international reports · 2026 · Journal Article
Suhlrie A, van der Meijden WAG, Faguer S, Alberici F, et al.
Pediatric nephrology (Berlin, Germany) · 2025 · Journal Article
Vivarelli M, Samuel S, Coppo R, Barratt J, et al.
Clinical kidney journal · 2025 · Journal Article
Raina R, Chan EY, Hu J, Moradiya P, et al.
Clinical immunology (Orlando, Fla.) · 2026 · Journal Article
Brevet P, Gillibert A, Le Goaréguer L, Lattard C, et al.
Clinical and experimental rheumatology · 2025 · Journal Article
de Maleprade B, Gérard B, Brevet P, Riou G, et al.
Biomedicines · 2022 · Journal Article
Font G, Walet-Balieu ML, Petit M, Burel C, et al.
The British journal of dermatology · 2026 · Journal Article
Tedbirt B, Lemieux A, Maho-Vaillant M, Schapman D, et al.
The British journal of dermatology · 2025 · Journal Article
Maho-Vaillant M, Lemieux A, Arnoult C, Lebourgeois L, et al.
Pediatric nephrology (Berlin, Germany) · 2023 · Journal Article
Mahi SL, Bahram S, Harambat J, Allard L, et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023 · Journal Article
Bernardi S, Seugé L, Boyer O
Clinical immunology (Orlando, Fla.) · 2026 · Journal Article
Brevet P, Gillibert A, Le Goaréguer L, Lattard C, et al.
Cornea · 2026 · Journal Article
Gaulier A, Nicol L, Lefevre S, Jaworski T, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Mirguet A, Aeschlimann FA, Lemelle I, Jaussaud R, et al.
Clinical kidney journal · 2025 · Journal Article
Raina R, Chan EY, Hu J, Moradiya P, et al.
Additional file 6: of Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
TNF receptor (TNFR)1 and TNFR2 have no effect on RasGRP1 and RasGRP3 gene expression level in T and B cells respectively. Quantitative PCR analysis was performed to measure RasGRP1 and RasGRP3 gene expression levels in T
Additional file 5: of Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
T cell activation induces an increase of RasGRP1 gene expression level. After T cell negative selection, cells were cultured with IL-2 and anti-CD3 antibody for 4 days (n = 3). a To evaluate the T cell activation status,
Additional file 4: of Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
T and B cell purity. After negative selection of peripheral blood mononuclear cells from healthy controls, buffy coat and rheumatoid arthritis patients, cytometric analysis of T and B cell purity was checked. a Cytometri
Additional file 7: of Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
TNFα has no effect on T cell apoptosis. After T cell negative selection, cells were cultured with or without TNFα for 48 and 72 hours. To measure apoptosis, a fluorescein isothiocyanate (FITC) annexin-V Apoptosis Detecti
Additional file 5: of Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
T cell activation induces an increase of RasGRP1 gene expression level. After T cell negative selection, cells were cultured with IL-2 and anti-CD3 antibody for 4 days (n = 3). a To evaluate the T cell activation status,
Additional file 6: of Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
TNF receptor (TNFR)1 and TNFR2 have no effect on RasGRP1 and RasGRP3 gene expression level in T and B cells respectively. Quantitative PCR analysis was performed to measure RasGRP1 and RasGRP3 gene expression levels in T
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Pediatric nephrology (Berlin, Germany) · 2024 · Journal Article
De Mutiis C, Wenderfer SE, Basu B, Bagga A, et al.
Pediatric nephrology (Berlin, Germany) · 2023 · Observational Study
Mary AL, Clave S, Rousset-Rouviere C, Berard E, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023 · Journal Article
Carrette M, Couderc L, Bubenheim M, Vidal A, et al.
Pediatric nephrology (Berlin, Germany) · 2023 · Case Reports
Innocenti S, Bernardi S, Prévot M, Saldmann A, et al.
Journal of nephrology · 2023 · Journal Article
Chbihi M, Eveillard LA, Riller Q, Brousse R, et al.